Dear Chairman Cassidy and Ranking Member Sanders:
The undersigned organizations represent patients, clinicians, researchers, professional societies, employers, and advocates committed to improving the health and well-being of people living with obesity.
We write to express our support for the Safeguarding Americans from Fraudulent and Experimental (SAFE) Drugs Act of 2025 (S. 3794) and respectfully urge the Senate Committee on Health, Education, Labor, and Pensions (HELP) to advance this legislation during its upcoming healthcare markup.
